+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Global Market Report 2020-30: COVID-19 Impact and Recovery

  • PDF Icon

    Report

  • September 2020
  • Region: Global
  • The Business Research Company
  • ID: 4856022
Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Global Market Report 2020-30: COVID-19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global benign prostatic hyperplasia (bph) treatment devices and equipment market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the benign prostatic hyperplasia (bph) treatment devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? the Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:
1) by Product: Resectoscopes; Radiofrequency ablation device; Urology lasers; Prostatic Stents; Implants
2) by End-User: Hospitals; Ambulatory Surgical Centres (ASC); Clinics; Home
3) by Procedure Type: Transurethral Needle Ablation (TUNA); Transurethral Resection of Prostate (TURP); Transurethral Incision of Prostate (TUIP); Transurethral microwave thermotherapy (TUMT); Laser surgery Others

Companies Mentioned: Karl Storz; Lumenis; Olympus; Urologix; Boston scientific Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary2. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Characteristics
3. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Size And Growth
3.1. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Historic Market, 2015-2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Segmentation
4.1. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Resectoscopes
  • Radiofrequency ablation device
  • Urology lasers
  • Prostatic Stents
  • Implants
4.2. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centres (ASC)
  • Clinics
  • Home
4.3. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Transurethral Needle Ablation (TUNA)
  • Transurethral Resection of Prostate (TURP)
  • Transurethral Incision of Prostate (TUIP)
  • Transurethral microwave thermotherapy (TUMT)
  • Laser surgery
  • Others

5. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Regional And Country Analysis
5.1. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
6.1. Asia-Pacific Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
6.2. Asia-Pacific Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7. China Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
7.1. China Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
7.2. China Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
8. India Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
8.1. India Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
8.2. India Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9. Japan Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
9.1. Japan Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
9.2. Japan Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10. Australia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
10.1. Australia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11. Indonesia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
11.1. Indonesia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12. South Korea Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
12.1. South Korea Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13. Western Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
13.1. Western Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
13.2. Western Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14. UK Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
14.1. UK Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
14.2. UK Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15. Germany Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
15.1. Germany Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16. France Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
16.4. France Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17. Eastern Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
17.1. Eastern Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
17.2. Eastern Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18. Russia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
18.1. Russia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19. North America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
19.1. North America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
19.2. North America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20. USA Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
20.1. USA Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
20.2. USA Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21. South America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
21.1. South America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
21.2. South America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22. Brazil Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
22.1. Brazil Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23. Middle East Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
23.1. Middle East Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
23.2. Middle East Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24. Africa Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
24.1. Africa Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
24.2. Africa Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
25. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Competitive Landscape And Company Profiles
25.1. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Competitive Landscape
25.2. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Company Profiles
25.2.1. Karl Storz
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Lumenis
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Olympus
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Urologix
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Boston scientific Inc.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Benign Prostatic Hyperplasia Treatment Devices and Equipment Market27. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Trends And Strategies28. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Future Outlook and Potential Analysis
29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright and Disclaimer

Executive Summary

Major players in the benign prostatic hyperplasia (BPH) treatment devices and equipment market are Karl Storz, Lumenis, Olympus, Urologix and Boston scientific Inc.

The global benign prostatic hyperplasia (bph) treatment devices and equipment market is expected to decline from $4.5 billion in 2019 to $4.1 billion in 2020 at a compound annual growth rate (CAGR) of -8.8%. The decline is mainly because of worldwide supply and demand mismatches of resources due to the COVID-19 outbreak. There is an inadequate production of nephrology and urology devices due to the restrictions imposed by governments of various countries to shutdown factories or function with minimal staffing to contain the spread of virus and keep the staff safe. The market is then expected to recover and grow at a CAGR of 4.3% from 2021 and reach $5.3 billion in 2023.

The benign prostatic hyperplasia (BPH) treatment devices and equipment market consists of sales of benign prostatic hyperplasia (BPH) treatment devices and equipment and related services. Benign prostatic hyperplasia or benign prostatic hypertrophy is a condition of an enlarged prostate gland which causes blockade of urethra, the tube that carries urine from the bladder. The market is segmented into resectoscopes, radiofrequency ablation device, urology lasers, prostatic stents and implants.

In 2018, Boston Scientific acquired NxThera for an upfront cash payment of $306 million, and up to an additional $100 million in potential commercial milestone payments over the next four years. This acquisition will strengthen Boston’s already existing urology and pelvic health portfolio range. The acquisition of NxThera would be the best fit along with Boston Scientific’s laser therapy systems for the treatment of symptomatic BPH such as the Greenlight XPSTM Laser Therapy system and holmium platforms. NxThera, Inc.is involved in the manufacturing of medical devices to treat patients suffering from urologic conditions such as benign prostatic hyperplasia (BPH), prostate cancer, and kidney cancer. It was founded in 2008 and is headquartered in Minnesota, USA.

The side effects suffered by the patients after a BPH procedure is one of the major restraints for BPH device and equipment market. For example, most common side effects of a BPH surgery includes, urinary incontinence, discomfort during urination and difficulty in completely emptying the bladder. The patients suffering from BPH does not prefer surgical procedures (till the stage it can be avoided) due to these side effects, therefore decreasing the demand of surgical procedures, which in turn limits the demand for devices used by end users like hospitals, clinics and ambulatory surgical centers.

Prostatic Astery Embolization (PAE) is one of the latest developments in the market for Benign Prostatic Hyperplasia (BPH) treatment device and equipment. PAE is a minimally invasive treatment that assists in reducing the symptoms observed in urinary tract. The PAE procedure is done using X-rays and other advanced imaging to observe the tumor inside the body and accordingly treat it without any surgery. This technique results in reduced complication in the treatment of BPH and thus is said to be a major development in the market of BPH treatment. Leading companies such as Boston scientifics, UNC healthcare, and Spire healthcare have been investing in the market for PAE.

Product recall is a process of retrieving all faulty and defective products that have been sold or are available in the market. When a company recalls a product from the market, the company bears all the cost of fixing the defective product and cost of replacement. This cost of replacement for large companies can go up to multi-million dollar, hence restraining the growth of the company and for the whole market as well. Product recall is one of the major hurdles for any market, Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment market is no exception. For example, in the year 2019, Procept BioRobotics Corporation recalled its AquaBeam Handpiece, a part of its AquaBeam Robotic System due to the possibility of developments of internal leak because of micro-cracks in specific weld joints within the product device. Also, in the year 2017, NXTHERA recalled its products like Rezum Systems and Vapor BPH Ablation System as the Needle Bond was not able to withstand the force when the needle was injected into and retracted from the prostate tissue in the treatment.

Benign Prostatic Hyperplasia (BPH) also called Prostate Gland Enlargement (PGE), is a condition where patient suffers from uncomfortable urinary symptoms. Due to rising prevalence of Benign Prostatic Hyperplasia (BPH), demand for the BPH treatment devices and equipment's is on a steady rise as the number of BPH cases increases the demand for devices will also increase. For example, in the USA by 2018, more than 8 million men are suffering from Benign Prostatic Hyperplasia (BPH) and globally around 22 million men have been diagnosed with moderate to severe symptoms of BPH. Therefore, with number of BPH cases on the steady rise, the demand for BPH treatment devices and equipment is also expected to grow.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Karl Storz
  • Lumenis
  • Olympus
  • Urologix
  • Boston scientific Inc.
  • Endo International
  • Neo tract
  • Lisa Laser (U.S.)
  • Medifocus Inc. (Canada)
  • ProArc Medical LTD. (Israel)
  • Olympus America
  • Teleflex
  • Medtronic
  • Urotech
  • Prostalund Operations AB
  • Baxter International
  • NxThera
  • Richard Wolf GmbH
  • Coloplast A/S
  • Siemens
  • Quest Pharmatech
  • Protox Therapeutics
  • IntelGenx Technologies Corp
  • Astellas Pharma Inc.
  • Ipsen S.A.

Methodology

Loading
LOADING...